Navigation Links
Haemacure Update on Proposed Collaboration and Bridge Financing
Date:5/22/2009

HAE:TSX

- Loan of US$2.5 Million Expected to Close by June 1, 2009

MONTREAL, May 22 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company, announces that it and Angiotech Pharmaceuticals, Inc. of Vancouver (NASDAQ: ANPI, TSX:ANP) are preparing definitive documentation for a previously-announced senior secured bridge loan from Angiotech to Haemacure in the amount of US$2.5 million. Haemacure and Angiotech expect that the closing of the bridge loan will take place on or about June 1, 2009.

The definitive loan agreement will provide that Angiotech will lend US$2.3 million to Haemacure in multiple draw-downs, in addition to US$200,000 advanced by Angiotech on May 1, 2009 upon the signing of a term sheet. Angiotech may, at its sole discretion, advance during a period of two years from the closing date up to an additional US$1 million to Haemacure from time to time, in multiple draw-downs, for a total loan of US$3.5 million.

The loan will be senior to all of Haemacure's existing and future indebtedness, subject to certain exceptions; bear interest at an annual rate of 10%, compounded quarterly; and have a term of two years. Haemacure estimates that the loan of US$2.5 million will allow it to continue operations until the end of 2009.

In the event of the closing of an equity financing by Haemacure in an amount of at least US$13.5 million, Angiotech will convert the entire principal amount of the loan and all accrued interest thereon into the same type of security as that issued by Haemacure in the equity financing, at a conversion price equal to the issue price of the equity financing less a discount of 15%, subject to the condition that Angiotech not be required to consolidate Haemacure's results in its financial statements as a consequence of such conversion.
'/>"/>

SOURCE Haemacure Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Haemacure Signs Term Sheet for Proposed Collaboration and Bridge Financing
2. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
3. Haemacure Restructures - Seeks Financing or Sale of the Company
4. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
5. Haemacure Announces Fiscal 2008 Results
6. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
7. Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
8. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
9. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
10. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
11. Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Robins & Morton received nine Excellence ... Contractors (ABC) of Alabama. , ABC will recognize ... Sheraton Birmingham Hotel., ,     HealthSouth Rehabilitation ... $25 Million, Obelisk Award (First Place) , ... Million to $25 Million, Obelisk Award (First Place) ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. ... control -- especially long-acting implanted devices -- could slash pregnancy ... new findings suggest. In a study of 1,400 teenage ... the girls, rates of unplanned pregnancy and abortion. Over three ... -- versus a rate of 158 per 1,000 among all ...
(Date:10/2/2014)... 1, 2014 (HealthDay News) -- Children with autism are ... fully capable of being more active, a small study ... of 29 children, some with autism and some without. ... of moderate physical activity and 70 more minutes each ... children with autism scored lower on strength, but had ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... that pull out all the stops to rescue surgical ... but the cost of such heroism is questionable, a ... 5 percent better at saving elderly patients with life-threatening ... with less intensity, said senior author Dr. Amir Ghaferi. ...
(Date:10/1/2014)... strongly associated with Alzheimer,s disease; however, researchers are still ... causal agent of the onset and development of the ... beta-amyloid is not harmful when found in isolation but ... to form the so-called amyloid fibrils , "We are ... with multiple ones because each aggregate of peptide, which ...
Breaking Medicine News(10 mins):Health News:Robins & Morton wins nine awards from Associated Builders and Contractors 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 3Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 4Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2
... IntraHealth International will highlight its ... the developing world during the 36th annual ... D.C., May 26-30. Hosted by the Global Health ... = Healthy Communities," focuses on the ways in which ...
... groups, headed by Prof. Nils Brose of the Max Planck ... on behalf of the European Union, to study the role ... the research teams is headed by Prof. Kobi Rosenblum of ... has been awarded a grant of 600,000 Euro. The topic ...
... reports MS medication possession ratio of 86 percent for ... Multiple sclerosis patients managed by a specialty pharmacy program ... risk of being hospitalized for their disease than those ... according to a study completed by HealthCore, Inc.HealthCore researcher ...
... Velocity,s intelligent search capabilities such as geo-spatial search, content ... May 19 Vivisimo ( www.vivisimo.com ), a leading ... that Bupa, an international health and care company with ... selected the Vivisimo Velocity Search Platform ...
... to provide sun protection, laughs and college scholarship ... Today non-profit Cancer for College launches a new ... proceeds from the sunscreen sales will go to ... granting college scholarships to cancer survivors and amputees.To ...
... mice might explain progression from skin to breathing condition ... secreted by eczema-damaged skin might trigger asthma in children, ... study of mice with an eczema-like condition, which suggested ... trigger substance might help prevent asthma. , An estimated ...
Cached Medicine News:Health News:IntraHealth International Addresses Capacity Building and Open Source Technologies at Tech-Themed Global Health Conference 2Health News:MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR 2Health News:MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR 3Health News:Vivisimo Powers Site Search on Bupa's Leading Health Information Websites Worldwide 2Health News:Photos: Will Ferrell Sunscreen to Launch Just in Time for Summer 2Health News:Molecule in Skin May Link Eczema and Asthma 2
(Date:10/2/2014)... Research and Markets  has announced the ... by Application, and by Geography - Global Forecast to ... The medical electronics market is expected to grow at ... the world due to growing income levels, and increasing ... hypertension, and cardiovascular diseases. A growing population coupled with ...
(Date:10/2/2014)... 2, 2014  Eli Lilly and Company (NYSE: ... tabalumab­ -- being studied for the treatment of ... -- due to insufficient efficacy in two pivotal ... on safety concerns. ­­­­ In the ... primary endpoint, at either dose studied, of statistically ...
(Date:10/2/2014)...  InfinityQS International, Inc., the global authority on ... client speakers for Infusion Chicago, its 9 th ... will be held Oct. 9-10, 2014, at the ... from Coloplast, The Kellogg Company, Biomet, General Cable, ... two-day event will also include best practice presentations ...
Breaking Medicine Technology:Medical Electronics (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU) Market - Global Forecast to 2020 2Medical Electronics (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU) Market - Global Forecast to 2020 3Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies 2Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies 3InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 2InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 3
... SAN DIEGO, Oct. 4 To mark the beginning ... its breast cancer treatment services at its West Houston ... Emission Mammography) scanners are high-resolution breast PET systems that ... of a lesion.  The metabolic view allows physicians to ...
... ALTOONA, Pa., Oct. 4 In response ... and the importance of "aging-in-place" as an ... Technologies, LLC ("Delta") today announced the introduction ... developed to optimize the homecare therapist. ...
Cached Medicine Technology:SightLine Health Adds Naviscan PEM Technology to Breast Cancer Treatment Services 2Delta Health Technologies ClinicalVirtuosoâ„¢ Targets Homecare Therapists 2
IVUS console...
FemoStop system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic and i...
VasoSeal ES is a extravascular arterial sealing. It utilizes a unique temporary arterial locator system which provides an easier and surer method of locating the femoral artery....
... was the first device ... after diagnostic and interventional ... It is a collagen-based ... for immediate sheath removal ...
Medicine Products: